1208 BIT225, AN HCV-P7 INHIBITOR, WITH ENHANCED ANTI-HCV ACTIVITY IN COMBINATION WITH PEGYLATED INTERFERONalfa- 2b AND RIBAVIRIN IN HCV GENOTYPE-1 TREATMENT NAÏVE SUBJECTS: PHARMACOKINETIC AND RESISTANCE STUDIES

✍ Scribed by Ewart, G.; Luscombe, C.; Huang, Z.; Miller, M.; Wilkinson, J.; Murphy, R.; Tanwandee, T.

• Book ID: 123484851
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 53 KB
• Volume: 58
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(13)61209-X